Dataset: The transcriptional landscape of hematopoietic stem cell ontogeny
[u'Transcriptome analysis of adult hematopoietic stem cells (HSC) and their progeny has informed our understanding of blood...
[u'Transcriptome analysis of adult hematopoietic stem cells (HSC) and their progeny has informed our understanding of blood differentiation and leukemogenesis, but a similarly transformative analysis of the embryonic origins of hematopoiesis is lacking. To address this issue, we acquired gene expression profiles of developing HSC purified from over 2500 dissected murine embryos and adult mice, and applied a network biology-based analysis to reconstruct the gene regulatory networks of sequential stages of HSC development. We found that embryonic hematopoietic elements clustered into three distinct transcriptional states characteristic of the definitive yolk sac, HSCs emerging from hemogenic endothelium, and definitive HSCs. We functionally validated several candidate transcriptional regulators of HSC ontogeny by morpholino-mediated knock-down in zebrafish embryos, confirming changes in the expression of HSC markers runx1 and c-myb in the aorta-gonads-mesonephros (AGM), the site of definitive HSC specification. Moreover, we found that HSCs derived from differentiating embryonic stem cells in vitro (ESC-HSC) most closely resemble definitive HSC, yet lack a signature indicative of specification by Notch signaling, which likely accounts for their deficient lymphoid development. Our analysis and accompanying web resource will accelerate the characterization of regulators of HSC ontogeny, facilitate efforts to direct hematopoietic differentiation and cell fate conversion, and serve as a model to study the origins of other adult stem cells. Hematopoietic stem cells and their precursors were isolated from mouse embryos and distinct stages and sites during development, purified by fluorescence activated cell sorting, and gene expression profiled on Affymetrix arrays. We also profiled HSCs and their precurors derived by in vitro differentitation of embryonic stem cells [expression data from GSE16925 and GSE14012 was used for mESCs, available at ', {u'a': {u'href': u'http://hsc.hms.harvard.edu/', u'target': u'_blank', u'$': u'http://hsc.hms.harvard.edu/'}}, u'].']
- Species:
- mouse
- Samples:
- 47
- Source:
- E-GEOD-37000
- Updated:
- Dec.12, 2014
- Registered:
- Nov.12, 2014
Sample | STRAIN BACKGROUND | AMPLIFICATION | ORGANISM PART | HSC STAGE | MARKERS | DEVELOPMENTAL STAGE | IN VIVO OR IN VITRO |
---|---|---|---|---|---|---|---|
GSM908278 | C57BL/6 | Nugen | aorta-gonads-mesonephros | Specifying | VE-cadherin+CD45+ | embryonic day 11.5 | in vivo |
GSM908278 | C57BL/6 | Nugen | aorta-gonads-mesonephros | Specifying | VE-cadherin+CD45+ | embryonic day 11.5 | in vivo |
GSM908278 | C57BL/6 | Nugen | aorta-gonads-mesonephros | Specifying | VE-cadherin+CD45+ | embryonic day 11.5 | in vivo |
GSM908278 | C57BL/6 | Nugen | aorta-gonads-mesonephros | Specifying | VE-cadherin+CD45+ | embryonic day 11.5 | in vivo |
GSM908278 | C57BL/6 | Nugen | aorta-gonads-mesonephros | Specifying | VE-cadherin+CD45+ | embryonic day 11.5 | in vivo |
GSM908278 | C57BL/6 | Nugen | aorta-gonads-mesonephros | Specifying | VE-cadherin+CD45+ | embryonic day 11.5 | in vivo |
GSM908284 | C57BL/6 x 129 cross | Nugen | not specified | YS-like | c-kit+CD41+ | differentiation day 6 | in vitro |
GSM908284 | C57BL/6 x 129 cross | Nugen | not specified | YS-like | c-kit+CD41+ | differentiation day 6 | in vitro |
GSM908286 | C57BL/6 x 129 cross | nan | not specified | YS-like | c-kit+CD41+ | differentiation day 6 | in vitro |
GSM908284 | C57BL/6 x 129 cross | Nugen | not specified | YS-like | c-kit+CD41+ | differentiation day 6 | in vitro |
GSM908286 | C57BL/6 x 129 cross | nan | not specified | YS-like | c-kit+CD41+ | differentiation day 6 | in vitro |
GSM908284 | C57BL/6 x 129 cross | Nugen | not specified | YS-like | c-kit+CD41+ | differentiation day 6 | in vitro |
GSM908290 | C57BL/6 x 129 cross | nan | not specified | Definitive | CD41brightCD45-CD34- | differentiation day 10-14 | in vitro |
GSM908290 | C57BL/6 x 129 cross | nan | not specified | Definitive | CD41brightCD45-CD34- | differentiation day 10-14 | in vitro |
GSM908290 | C57BL/6 x 129 cross | nan | not specified | Definitive | CD41brightCD45-CD34- | differentiation day 10-14 | in vitro |
GSM908293 | C57BL/6 | Nugen | fetal liver | Definitive | Lin-Sca-1+c-kit+VE-cadherin+Mac-1low | embryonic day 12.5 | in vivo |
GSM908294 | C57BL/6 | Nugen | fetal liver | Specifying | Lin-Sca-1+c-kit+VE-cadherin+Mac-1low | embryonic day 12.5 | in vivo |
GSM908294 | C57BL/6 | Nugen | fetal liver | Specifying | Lin-Sca-1+c-kit+VE-cadherin+Mac-1low | embryonic day 12.5 | in vivo |
GSM908293 | C57BL/6 | Nugen | fetal liver | Definitive | Lin-Sca-1+c-kit+VE-cadherin+Mac-1low | embryonic day 12.5 | in vivo |
GSM908293 | C57BL/6 | Nugen | fetal liver | Definitive | Lin-Sca-1+c-kit+VE-cadherin+Mac-1low | embryonic day 12.5 | in vivo |
GSM908293 | C57BL/6 | Nugen | fetal liver | Definitive | Lin-Sca-1+c-kit+VE-cadherin+Mac-1low | embryonic day 12.5 | in vivo |
GSM908299 | C57BL/6 | Nugen | fetal liver | Definitive | Lin-Sca-1+c-kit+CD150+CD48- | embryonic day 13.5 | in vivo |
GSM908299 | C57BL/6 | Nugen | fetal liver | Definitive | Lin-Sca-1+c-kit+CD150+CD48- | embryonic day 13.5 | in vivo |
GSM908299 | C57BL/6 | Nugen | fetal liver | Definitive | Lin-Sca-1+c-kit+CD150+CD48- | embryonic day 13.5 | in vivo |
GSM908299 | C57BL/6 | Nugen | fetal liver | Definitive | Lin-Sca-1+c-kit+CD150+CD48- | embryonic day 13.5 | in vivo |
GSM908303 | C57BL/6 | nan | fetal liver | Definitive | Lin-Sca-1+c-kit+CD150+CD48- | embryonic day 14.5 | in vivo |
GSM908304 | C57BL/6 | Nugen | fetal liver | Definitive | Lin-Sca-1+c-kit+CD150+CD48- | embryonic day 14.5 | in vivo |
GSM908303 | C57BL/6 | nan | fetal liver | Definitive | Lin-Sca-1+c-kit+CD150+CD48- | embryonic day 14.5 | in vivo |
GSM908304 | C57BL/6 | Nugen | fetal liver | Definitive | Lin-Sca-1+c-kit+CD150+CD48- | embryonic day 14.5 | in vivo |
GSM908303 | C57BL/6 | nan | fetal liver | Definitive | Lin-Sca-1+c-kit+CD150+CD48- | embryonic day 14.5 | in vivo |
GSM908304 | C57BL/6 | Nugen | fetal liver | Definitive | Lin-Sca-1+c-kit+CD150+CD48- | embryonic day 14.5 | in vivo |
GSM908309 | C57BL/6 | nan | placenta | Specifying | CD45+CD34medc-kit+ | embryonic day 12.5 | in vivo |
GSM908309 | C57BL/6 | nan | placenta | Specifying | CD45+CD34medc-kit+ | embryonic day 12.5 | in vivo |
GSM908309 | C57BL/6 | nan | placenta | Specifying | CD45+CD34medc-kit+ | embryonic day 12.5 | in vivo |
GSM908312 | C57BL/6 | Nugen | placenta | Specifying | CD45+CD34medc-kit+ | embryonic day 12.5 | in vivo |
GSM908312 | C57BL/6 | Nugen | placenta | Specifying | CD45+CD34medc-kit+ | embryonic day 12.5 | in vivo |
GSM908312 | C57BL/6 | Nugen | placenta | Specifying | CD45+CD34medc-kit+ | embryonic day 12.5 | in vivo |
GSM908315 | C57BL/6 | nan | bone marrow | Definitive | Lin-Sca-1+c-kit+CD150+CD34- | adult | in vivo |
GSM908316 | C57BL/6 | Nugen | bone marrow | Definitive | Lin-Sca-1+c-kit+CD150+CD34- | adult | in vivo |
GSM908316 | C57BL/6 | Nugen | bone marrow | Definitive | Lin-Sca-1+c-kit+CD150+CD34- | adult | in vivo |
GSM908315 | C57BL/6 | nan | bone marrow | Definitive | Lin-Sca-1+c-kit+CD150+CD34- | adult | in vivo |
GSM908316 | C57BL/6 | Nugen | bone marrow | Definitive | Lin-Sca-1+c-kit+CD150+CD34- | adult | in vivo |
GSM908320 | C57BL/6 | nan | yolk sac | YS-like | CD41+CD34+c-kit+ | embryonic day 9 | in vivo |
GSM908320 | C57BL/6 | nan | yolk sac | YS-like | CD41+CD34+c-kit+ | embryonic day 9 | in vivo |
GSM908320 | C57BL/6 | nan | yolk sac | YS-like | CD41+CD34+c-kit+ | embryonic day 9 | in vivo |
GSM908323 | C57BL/6 | Nugen | yolk sac | YS-like | CD41+CD34+c-kit+ | embryonic day 9 | in vivo |
GSM908323 | C57BL/6 | Nugen | yolk sac | YS-like | CD41+CD34+c-kit+ | embryonic day 9 | in vivo |